Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28379796

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Apr 6
First author
Attal M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 Aug;14(8):461-462. doi: 10.1038/nrclinonc.2017.82.
    note
    Source null
    related pmid
    28607521
    relationship
    Comment in
  2. citation
    N Engl J Med. 2017 Jul 6;377(1):91-2. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28679086
    relationship
    Comment in
  3. citation
    N Engl J Med. 2017 Jul 6;377(1):92. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28679087
    relationship
    Comment in
  4. citation
    N Engl J Med. ;377(1):92-3. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28691787
    relationship
    Comment in

Authors and identifiers

  1. name
    Attal M
    type
    Author
  2. name
    Lauwers-Cances V
    type
    Author
  3. name
    Hulin C
    type
    Author
  4. name
    Leleu X
    type
    Author
  5. name
    Caillot D
    type
    Author
  6. name
    Escoffre M
    type
    Author
  7. name
    Arnulf B
    type
    Author
  8. name
    Macro M
    type
    Author
  9. name
    Belhadj K
    type
    Author
  10. name
    Garderet L
    type
    Author
  11. name
    Roussel M
    type
    Author
  12. name
    Payen C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Attal M
    type
    Author
  2. name
    Lauwers-Cances V
    type
    Author
  3. name
    Hulin C
    type
    Author
  4. name
    Leleu X
    type
    Author
  5. name
    Caillot D
    type
    Author
  6. name
    Escoffre M
    type
    Author
  7. name
    Arnulf B
    type
    Author
  8. name
    Macro M
    type
    Author
  9. name
    Belhadj K
    type
    Author
  10. name
    Garderet L
    type
    Author
  11. name
    Roussel M
    type
    Author
  12. name
    Payen C
    type
    Author
bibliography ids
  1. nci-bib-7004318d19be5d20904baf8c
book metadata
content sha256
aa6a07faa02531a8295d30de17027b9720e76f285cda26211f44f893bef3c5cd
document type
citation
dois
  1. 10.1056/NEJMoa1611750
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28379796
immutable id
pubmed:28379796@aa6a07faa02531a8295d30de17027b9720e76f285cda26211f44f893bef3c5cd
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
14
name
The New England journal of medicine
nlm unique id
0255562
pages
1311-1320
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 Aug;14(8):461-462. doi: 10.1038/nrclinonc.2017.82.
    note
    Source null
    related pmid
    28607521
    relationship
    Comment in
  2. citation
    N Engl J Med. 2017 Jul 6;377(1):91-2. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28679086
    relationship
    Comment in
  3. citation
    N Engl J Med. 2017 Jul 6;377(1):92. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28679087
    relationship
    Comment in
  4. citation
    N Engl J Med. ;377(1):92-3. doi: 10.1056/NEJMc1705671.
    note
    Source null
    related pmid
    28691787
    relationship
    Comment in
outcomes validated
false
pmid
28379796
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
1ec6c0be3aef6c3ba800da3f9115e99c4ac4d8c41fc92b983dcd8b97ececabfc
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Apr 6
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28379796/
title
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

Preserved source evidence · Not medical advice